Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Preferred Shares (2017 - 2020)

Aytu Biopharma (AYTU) has disclosed Preferred Shares for 4 consecutive years, with $981.0 as the latest value for Q1 2020.

  • Quarterly Preferred Shares rose 319.23% to $981.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $981.0 through Mar 2020, up 319.23% year-over-year, with the annual reading at $359.0 for FY2019, N/A changed from the prior year.
  • Preferred Shares for Q1 2020 was $981.0 at Aytu Biopharma, down from $1022.0 in the prior quarter.
  • The five-year high for Preferred Shares was $1022.0 in Q4 2019, with the low at $1.0 in Q3 2017.
  • Average Preferred Shares over 4 years is $420.75, with a median of $337.0 recorded in 2019.
  • The sharpest move saw Preferred Shares skyrocketed 45200.0% in 2018, then surged 125.61% in 2019.
  • Over 4 years, Preferred Shares stood at $1.0 in 2017, then surged by 45200.0% to $453.0 in 2018, then soared by 125.61% to $1022.0 in 2019, then fell by 4.01% to $981.0 in 2020.
  • According to Business Quant data, Preferred Shares over the past three periods came in at $981.0, $1022.0, and $315.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.